$CVX
CHEVRON CORP

2023 Q3 Form 10-Q Financial Statement

#000009341023000088 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $54.08B
YoY Change -14.85%
Cost Of Revenue $32.33B
YoY Change -15.13%
Gross Profit $21.75B
YoY Change -14.42%
Gross Profit Margin 40.22%
Selling, General & Admin $1.163B
YoY Change -87.49%
% of Gross Profit 5.35%
Research & Development $301.0M
YoY Change 159.48%
% of Gross Profit 1.38%
Depreciation & Amortization $4.025B
YoY Change -4.19%
% of Gross Profit 18.5%
Operating Expenses $1.163B
YoY Change -90.98%
Operating Profit $20.59B
YoY Change 64.36%
Interest Expense $1.199B
YoY Change -47.46%
% of Operating Profit 5.82%
Other Income/Expense, Net -$91.00M
YoY Change -56.25%
Pretax Income $8.700B
YoY Change -41.25%
Income Tax $2.200B
% Of Pretax Income 25.29%
Net Earnings $6.526B
YoY Change -41.89%
Net Earnings / Revenue 12.07%
Basic Earnings Per Share $3.48
Diluted Earnings Per Share $3.48
COMMON SHARES
Basic Shares Outstanding 1.871B shares
Diluted Shares Outstanding 1.877B shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.938B
YoY Change -61.52%
Cash & Equivalents $5.797B
Short-Term Investments $141.0M
Other Short-Term Assets $4.373B
YoY Change -5.02%
Inventory $9.428B
Prepaid Expenses $4.373B
Receivables $19.50B
Other Receivables $0.00
Total Short-Term Assets $41.73B
YoY Change -18.97%
LONG-TERM ASSETS
Property, Plant & Equipment $154.0B
YoY Change 6.82%
Goodwill $4.722B
YoY Change 1.27%
Intangibles
YoY Change
Long-Term Investments $48.12B
YoY Change 6.58%
Other Assets $13.67B
YoY Change 7.25%
Total Long-Term Assets $222.2B
YoY Change 6.71%
TOTAL ASSETS
Total Short-Term Assets $41.73B
Total Long-Term Assets $222.2B
Total Assets $263.9B
YoY Change 1.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.65B
YoY Change -0.23%
Accrued Expenses $7.618B
YoY Change 6.09%
Deferred Revenue
YoY Change
Short-Term Debt $440.0M
YoY Change -80.19%
Long-Term Debt Due $440.0M
YoY Change -80.19%
Total Short-Term Liabilities $33.26B
YoY Change -9.81%
LONG-TERM LIABILITIES
Long-Term Debt $20.12B
YoY Change -6.07%
Other Long-Term Liabilities $24.66B
YoY Change -2.1%
Total Long-Term Liabilities $44.78B
YoY Change -3.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.26B
Total Long-Term Liabilities $44.78B
Total Liabilities $97.68B
YoY Change -2.43%
SHAREHOLDERS EQUITY
Retained Earnings $200.6B
YoY Change 7.62%
Common Stock $23.15B
YoY Change 13.37%
Preferred Stock
YoY Change
Treasury Stock (at cost) $55.64B
YoY Change 24.42%
Treasury Stock Shares
Shareholders Equity $165.3B
YoY Change
Total Liabilities & Shareholders Equity $263.9B
YoY Change 1.61%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income $6.526B
YoY Change -41.89%
Depreciation, Depletion And Amortization $4.025B
YoY Change -4.19%
Cash From Operating Activities $9.673B
YoY Change -36.64%
INVESTING ACTIVITIES
Capital Expenditures $4.673B
YoY Change -256.03%
Acquisitions
YoY Change
Other Investing Activities $263.0M
YoY Change 15.35%
Cash From Investing Activities -$4.410B
YoY Change 59.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.621B
YoY Change -4.48%
NET CHANGE
Cash From Operating Activities 9.673B
Cash From Investing Activities -4.410B
Cash From Financing Activities -8.621B
Net Change In Cash -3.358B
YoY Change -196.63%
FREE CASH FLOW
Cash From Operating Activities $9.673B
Capital Expenditures $4.673B
Free Cash Flow $5.000B
YoY Change -72.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
153972000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
143591000000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
55640000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
48196000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-55000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2862000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8139000000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
410000000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2485000000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-84000000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-82000000 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
38000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11161000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8396000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-33000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
278000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
150000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
4207000000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
8449000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8527000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8255000000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-44000000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-103000000 usd
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-11281000000 usd
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-2000000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23942000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18529000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-187000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-277000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12115000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9902000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7006000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16697000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
154562000000 usd
CY2022Q3 cvx Adjustments To Additional Paid In Capital
AdjustmentsToAdditionalPaidInCapital
19000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
11238000000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.42
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2814000000 usd
CY2022Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
2000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
318000000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3750000000 usd
CY2022Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-2000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
159627000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
159298000000 usd
CY2023Q3 cvx Adjustments To Additional Paid In Capital
AdjustmentsToAdditionalPaidInCapital
43000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
11468000000 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-242000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
54000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6520000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
6555000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.51
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2897000000 usd
CY2023Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
6000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
114000000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3424000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
56000000 usd
CY2023Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
11000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
166248000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
139940000000 usd
cvx Adjustments To Additional Paid In Capital
AdjustmentsToAdditionalPaidInCapital
49000000 usd
us-gaap Profit Loss
ProfitLoss
29230000000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
4.26
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8362000000 usd
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
3000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
716000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7505000000 usd
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
5505000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-57000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
159627000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
160242000000 usd
cvx Adjustments To Additional Paid In Capital
AdjustmentsToAdditionalPaidInCapital
123000000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6520000000 usd
us-gaap Profit Loss
ProfitLoss
19168000000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
4.53
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8581000000 usd
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
7000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
201000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
11631000000 usd
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
237000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
24000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
166248000000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1832000000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1832000000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1832000000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1832000000 usd
CY2022Q3 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
240000000 usd
CY2023Q2 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
240000000 usd
CY2023Q3 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
240000000 usd
CY2022Q4 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
240000000 usd
CY2022Q3 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
14168000 shares
CY2022Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
14168000 shares
CY2021Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
14168000 shares
CY2022Q2 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
14168000 shares
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-33000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
278000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-33000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
278000000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
54000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1868000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2194000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4141000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6962000000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
2273000000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
4768000000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
890000000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
4428000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1136000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2170000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1121000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
479000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1706000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5282000000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2740000000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2967000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
4181000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-1172000000 usd
us-gaap Interest Paid Net
InterestPaidNet
292000000 usd
us-gaap Interest Paid Net
InterestPaidNet
320000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
8189000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
6750000000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
218000000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
1406000000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
192000000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1079000000 usd
cvx Proceeds From Sale Of Productive Assets And Equity Method Investment
ProceedsFromSaleOfProductiveAssetsAndEquityMethodInvestment
410000000 usd
cvx Proceeds From Sale Of Productive Assets And Equity Method Investment
ProceedsFromSaleOfProductiveAssetsAndEquityMethodInvestment
2485000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
289000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9000000 usd
cvx Marketable Securities Sold
MarketableSecuritiesSold
373000000 usd
cvx Marketable Securities Sold
MarketableSecuritiesSold
91000000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-84000000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-82000000 usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
296000000 usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
27000000 usd
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
54000000 usd
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
65000000 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-242000000 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
38000000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
107000000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
10000000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4000000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-44000000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-103000000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
237000000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5505000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11518000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7505000000 usd
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-11281000000 usd
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-2000000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.51
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.42
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
10602000000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
636000000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
932000000 usd
us-gaap Results Of Operations Dry Hole Costs
ResultsOfOperationsDryHoleCosts
205000000 usd
us-gaap Results Of Operations Dry Hole Costs
ResultsOfOperationsDryHoleCosts
137000000 usd
cvx Payments To Acquire Other Productive Assets Liabilities
PaymentsToAcquireOtherProductiveAssetsLiabilities
25000000 usd
cvx Payments To Acquire Other Productive Assets Liabilities
PaymentsToAcquireOtherProductiveAssetsLiabilities
169000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
11468000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8139000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5797000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15164000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17678000000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5640000000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
306000000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
742000000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
630000000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
333000000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
903000000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
791000000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
813000000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
822000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7006000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16697000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19121000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6795000000 usd
CY2023Q3 cvx Increase Decrease In Income Loss From Continuing Operations Before Equity Method Investments Income Taxes Noncontrolling Interest
IncreaseDecreaseInIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsIncomeTaxesNoncontrollingInterest
-6100000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14800000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8700000000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10600000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6900000000 usd
cvx Increase Decrease In Income Loss From Continuing Operations Before Equity Method Investments Income Taxes Noncontrolling Interest
IncreaseDecreaseInIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsIncomeTaxesNoncontrollingInterest
-13800000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6526000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
11231000000 usd
us-gaap Net Income Loss
NetIncomeLoss
19110000000 usd
us-gaap Net Income Loss
NetIncomeLoss
29112000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
4722000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4722000000 usd
CY2023Q3 us-gaap Assets
Assets
263927000000 usd
CY2022Q4 us-gaap Assets
Assets
257709000000 usd
cvx Maximum Annual Increase Percentage To Company Contribution For Retiree Medical Coverage
MaximumAnnualIncreasePercentageToCompanyContributionForRetireeMedicalCoverage
0.04
us-gaap Other Postretirement Benefits Payments
OtherPostretirementBenefitsPayments
123000000 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
651000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3600000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39900000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26100000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5800000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
17700000000 usd
CY2023Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
1200000000 usd
CY2022Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
1400000000 usd
CY2023Q3 cvx Deferred Gains Losses In Accumulated Other Comprehensive Losses Due To Outstanding Crude Oil Price Hedging Contracts
DeferredGainsLossesInAccumulatedOtherComprehensiveLossesDueToOutstandingCrudeOilPriceHedgingContracts
-16000000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
15200000000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
14200000000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
724000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
1000000000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19500000000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
4300000000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000093410-23-000088-index-headers.html Edgar Link pending
0000093410-23-000088-index.html Edgar Link pending
0000093410-23-000088.txt Edgar Link pending
0000093410-23-000088-xbrl.zip Edgar Link pending
a09302023ex101dcpii.htm Edgar Link pending
a09302023ex102rrp.htm Edgar Link pending
a09302023ex103cip.htm Edgar Link pending
a09302023ex1042022ltip.htm Edgar Link pending
a09302023ex1052013ltip.htm Edgar Link pending
a09302023ex311ceo-sox302.htm Edgar Link pending
a09302023ex312cfo-sox302.htm Edgar Link pending
a09302023ex321ceo-sox906.htm Edgar Link pending
a09302023ex322cfo-sox906.htm Edgar Link pending
cvx-20230930.htm Edgar Link pending
cvx-20230930.xsd Edgar Link pending
cvx-20230930_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
cvx-20230930_def.xml Edgar Link unprocessable
cvx-20230930_pre.xml Edgar Link unprocessable
cvx-20230930_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cvx-20230930_cal.xml Edgar Link unprocessable
cvx-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable